Neurotech Centre
FDA Cleared High Insurance Coverage

Transcranial Magnetic Stimulation (TMS)

TMS is a non-invasive procedural therapy that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of major depression. It is typically deployed when patients have failed to respond to standard antidepressant medications.

How it Works

An electromagnetic coil is placed against the scalp near the forehead. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of the brain involved in mood control and depression (typically the left dorsolateral prefrontal cortex).

Standard protocols involve daily sessions (5 days a week) for 4 to 6 weeks, each lasting between 19 and 37 minutes depending on the specific machine and protocol used (e.g., standard vs. Theta Burst Stimulation).

Clinical Efficacy

The Data: Real-World Outcomes

  • Response Rate: ~50-60% of patients experience a clinically significant reduction in depression symptoms (typically defined as a ≥50% reduction in PHQ-9 or MADRS scores).
  • Remission Rate: ~30-40% of patients achieve full remission.
  • Durability: For those who respond, benefits typically last 6-12 months. Maintenance sessions are often required.

Sources: Carpenter et al. (2012) Clinical TMS Society Consensus Review; NIMH funded OPT-TMS trial.

Cost and Insurance

A full course of TMS (36 sessions) typically costs between $6,000 and $12,000 out-of-pocket. However, unlike most other neurotech interventions, TMS is widely covered by commercial insurance, Medicare, and Tricare for Major Depressive Disorder (MDD).

Standard Insurance Prerequisites for MDD:

  1. Confirmed diagnosis of severe Major Depressive Disorder.
  2. Documented failure to achieve satisfactory improvement from at least 2-4 different antidepressant medications (from at least 2 different classes) in the current depressive episode.
  3. History of evidence-based psychotherapy without significant improvement.

Common Side Effects

TMS is generally well-tolerated. It does not require anesthesia and does not cause the cognitive side effects or memory loss associated with Electroconvulsive Therapy (ECT).

  • Scalp pain or discomfort at the treatment site (common, usually subsides after first week).
  • Headache (common).
  • Tingling, spasms or twitching of facial muscles during the treatment.
  • Seizures (rare risk, roughly 1 in 30,000 treatments).